Navigation Links
TorreyPines Therapeutics Reports Third Quarter 2007 Results
Date:11/14/2007

es' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements, including whether the results of the Phase IIb trial are predictive of results in subsequent trials of tezampanel, whether any preclinical studies or clinical trials, either ongoing or conducted in the future, will prove successful, and if successful, whether the results can be replicated; whether safety and efficacy profiles of any of its drug candidates will be established, or if established, will remain the same, be better or worse in future clinical trials, if any; whether pre-clinical results will be substantiated by ongoing or future clinical trials, if any, or whether any of its drug candidates will be able to improve the signs or symptoms of their respective clinical indication; whether any of its drug candidates will support a filing for marketing approval, will be approved by the regulatory authorities, or if approved, will prove competitive in the market; or whether the necessary financing to support the company's drug development programs will be available. In particular there is no guarantee that clinical trials of any of the company's product candidates will be completed on schedule or that results of these clinical trials will be reported within the anticipated timeframe, that tezampanel will successfully treat migraine pain, that NGX267 will successfully treat the symptoms of cognitive impairment associated with schizophrenia, that NGX267 will successfully treat xerostomia or that TorreyPines will be able to complete the necessary development work and receive regulatory approval for tezampanel or NGX267. These and other risks which may cause results to differ are described in greater detail in the "Risk Factors" section of TorreyPines' annual report on Form 10-K for the year ended December 31,2006 and TorreyPines other SEC reports. The forward-looking statements are based on current information that is lik
'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 Health eCareers, the ... Nurses Association (ENA) this week announced the launch of ... job board. The ENA Job Center provides ... professional members to find job openings and for employers ... nursing professionals working in the field. ...
(Date:3/6/2015)... , March 6, 2015  Attorney Advertising-- Bronstein, ... on behalf of purchasers of the securities of ... OREX -News).  Such investors are ... his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Orexigen and certain of ...
(Date:3/6/2015)... 06, 2015 Anton Paar has released ... by utilizing laboratory refractometers. Sodium hydroxide (NaOH, also ... producing a variety of products including pretzels, colored fabrics, ... staple of the chemical industry; its applications range from ... nearly everything in between. NaOH is used in ...
(Date:3/5/2015)... , March 5, 2015   HX360 ... semi-finalists in the HX360 Innovation Challenge competition. ... will compete to be chosen as one of four ... of senior health system executives and venture capitalists during ... Innovation Challenge takes place at the 2015 HIMSS Annual ...
Breaking Biology Technology:Health eCareers Announces Online Career Center for the Emergency Nurses Association 2Health eCareers Announces Online Career Center for the Emergency Nurses Association 3SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Orexigen Therapeutics, Inc. 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 3HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 4
... HORSHAM, Pa., April 2, 2012 Grammy ® -nominated ... and Janssen Biotech, Inc. are teaming up on ... M.A.P. , a new program designed to raise awareness ... and its disproportionate impact on the African-American community.  With ...
... Barbara, Calif.) A team of physicists at UC Santa ... different colors. By aiming high- and low-frequency laser beams at ... their cores, accelerated, and then smashed back into the cores ... simultaneously. Their findings appear in the current issue of the ...
... March 29, 2012  Islet Sciences, Inc., (OTC.BB: ISLT) ... and commercialization of patented technologies in the field ... today that its subsidiary DiaKine Therapeutics Inc. received ... that can be used to treat diabetes, atherosclerosis ...
Cached Biology Technology:Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 2Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 3Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 4Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 5UCSB Physicists mix 2 lasers to create light at many frequencies 2UCSB Physicists mix 2 lasers to create light at many frequencies 3Islet Sciences Announces DiaKine Therapeutics' Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection 2Islet Sciences Announces DiaKine Therapeutics' Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection 3
(Date:2/24/2015)... -- This report analyzes the worldwide markets for Iris Biometrics ... the US, Canada , Japan ... , Middle East , and ... provided for the period 2013 through 2020. Also, a seven-year ... analytics are derived from primary and secondary research. Company profiles ...
(Date:2/18/2015)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. , Cowen and ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern Time ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern ... webcasts for these events, please visit Cepheid,s website at ...
(Date:2/10/2015)... Inc. (NYSE: ALR), a global leader in rapid ... ended December 31, 2014. Namal Nawana, ... "We made substantial progress in the fourth quarter ... rapid diagnostics and delivering against our financial plans.  ... January enabled us to substantially reduce our debt, ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
... Second Life, female avatars expose substantially more skin than ... research published December 26 in the open access journal ... from Laval University, Canada. The human tendency ... cultural constraints, so measuring people,s propensity to reveal skin ...
... -- A series of rapid environmental changes in East ... for driving human evolution, according to researchers at Penn ... inhabiting transitioned rapidly back and forth between a closed ... times during a period of 200,000 years," said Clayton ...
... 2012 OpGen, Inc. today announced its ARGUS ... with next-generation sequencing (NGS) to produce the first, high-quality ... was led by BGI-Shenzhen and Kunming Institute of Zoology, ... Nature Biotechnology . The paper, titled Sequencing ...
Cached Biology News:Fluctuating environment may have driven human evolution 2Fluctuating environment may have driven human evolution 3OpGen announces sequence assembly and finishing of first reference genome of domestic goat 2
... up to 30 minutes of walkaway time. Automatic Calibration. Five minute cooldown from turn-on. ... ... ... ...
... pipets ,Angled acrylic pipet rack offers easy access ... pipet cans. Constructed of 6 mm (1/4 in.) thick ... 76 mm H x 289 mm D (3 x ... W x 406 mm H x 292 mm D ...
...
CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* Cell Biology Imaging Tools and Accessories Microscope Slide Accessories...
Biology Products: